Advertisement
Screener

TransMedics Group, Inc. (TMDX) Increase Decrease In Operating Lease Liability

2.8 / 5 stars · 68/120 Roast Me

TransMedics Group, Inc. Increase Decrease In Operating Lease Liability

TransMedics Group, Inc. (TMDX) reported Increase Decrease In Operating Lease Liability of -$1.59 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-04

  • TransMedics Group, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$783.00K.
  • TransMedics Group, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$805.00K.
  • TransMedics Group, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$777.00K.
  • TransMedics Group, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$740.00K.
  • TransMedics Group, Inc. increase decrease in operating lease liability for fiscal 2025 was -$2.90M.
  • TransMedics Group, Inc. increase decrease in operating lease liability for fiscal 2024 was -$2.27M.
  • TransMedics Group, Inc. increase decrease in operating lease liability for fiscal 2023 was -$1.57M, a 717.25% decline from fiscal 2022.
  • TransMedics Group, Inc. increase decrease in operating lease liability for fiscal 2022 was $255.00K, a 8.05% increase from fiscal 2021.
Period endIncrease Decrease In Operating Lease Liability 3 monthIncrease Decrease In Operating Lease Liability 6 monthIncrease Decrease In Operating Lease Liability 9 monthIncrease Decrease In Operating Lease Liability 12 month
2026-06-30-$783.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$1.59M
10-Q · filed 2026-08-04
-$2.37M
derived: sum of 3 quarters · filed 2026-08-04
-$3.10M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31-$805.00K
10-Q · filed 2026-05-05
-$1.58M
derived: sum of 2 quarters · filed 2026-05-05
-$2.32M
derived: sum of 3 quarters · filed 2026-05-05
-$3.04M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31-$777.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$1.52M
derived: sum of 2 quarters · filed 2026-02-24
-$2.23M
derived: sum of 3 quarters · filed 2026-08-04
-$2.90M
10-K · filed 2026-02-24
2025-09-30-$740.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
-$1.45M
derived: sum of 2 quarters · filed 2026-08-04
-$2.12M
10-Q · filed 2025-10-29
-$2.76M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30-$714.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$1.38M
10-Q · filed 2026-08-04
-$2.02M
derived: sum of 3 quarters · filed 2026-08-04
-$2.64M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31-$664.00K
10-Q · filed 2026-05-05
-$1.30M
derived: sum of 2 quarters · filed 2026-05-05
-$1.93M
derived: sum of 3 quarters · filed 2026-05-05
-$2.43M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31-$639.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$1.26M
derived: sum of 2 quarters · filed 2026-02-24
-$1.77M
derived: sum of 3 quarters · filed 2026-02-24
-$2.27M
10-K · filed 2026-02-24
2024-09-30-$626.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
-$1.13M
derived: sum of 2 quarters · filed 2025-10-29
-$1.63M
10-Q · filed 2025-10-29
-$2.10M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30-$504.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30
-$1.00M
10-Q · filed 2025-07-30
-$1.47M
derived: sum of 3 quarters · filed 2026-02-24
-$1.83M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31-$496.00K
10-Q · filed 2025-05-08
-$969.00K
derived: sum of 2 quarters · filed 2026-02-24
-$1.33M
derived: sum of 3 quarters · filed 2026-02-24
-$1.72M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31-$473.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$832.00K
derived: sum of 2 quarters · filed 2026-02-24
-$1.22M
derived: sum of 3 quarters · filed 2026-02-24
-$1.57M
10-K · filed 2026-02-24
2023-09-30-$359.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
-$749.00K
derived: sum of 2 quarters · filed 2024-10-29
-$1.10M
10-Q · filed 2024-10-29
-$1.44M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$390.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01
-$742.00K
10-Q · filed 2024-08-01
-$1.08M
derived: sum of 3 quarters · filed 2025-02-27
-$1.41M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$352.00K
10-Q · filed 2024-05-02
-$687.00K
derived: sum of 2 quarters · filed 2025-02-27
-$1.01M
derived: sum of 3 quarters · filed 2025-02-27
-$1.34M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$335.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$663.00K
derived: sum of 2 quarters · filed 2025-02-27
-$986.00K
derived: sum of 3 quarters · filed 2025-02-27
$255.00K
10-K · filed 2025-02-27
2022-09-30-$328.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$651.00K
derived: sum of 2 quarters · filed 2023-11-08
$590.00K
10-Q · filed 2023-11-08
2022-06-30-$323.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
$918.00K
10-Q · filed 2023-08-04
2022-03-31$1.24M
10-Q · filed 2023-05-04
2021-12-31$236.00K
10-K · filed 2024-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Axogen, Inc. (AXGN)United States$2.329B-73.83
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
LivaNova PLC (LIVN)$4.158B24.01
Integer Holdings Corp (ITGR)United States$4.289B25.17
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53